Introduction {#S1}
============

Bacteriocins are ribosomally synthesized proteins and protein complexes with a broad spectrum of antibacterial activities against many food-borne pathogens and closely related species ([@B15]). They do not affect cells that produce immune-related proteins ([@B19]). Bacteriocins from lactic acid bacteria (LAB) are non-toxic, highly potent, and safe, and so have been widely used as preservatives for foods that include vegetables, meats, and other food products ([@B25]; [@B67]). Bacteriocins may be developed as viable alternatives to antibiotics ([@B17]).

*Enterococcus* is a genus of LAB. The bacteria are Gram-positive, catalase-negative, facultative anaerobic, and non-spore forming ([@B45]). Enterococci, the first LAB colonizing the infant gastrointestinal tract (GIT) ([@B22]), are also ubiquitous in fermented foods and the environment ([@B24]; [@B23]). Furthermore, some *Enterococcus* spp. are commercially available and prevent numerous diseases. As examples, *Enterococcus faecium* SF68^®^ has been used as a food biopreservatives and in the treatment of diarrhea ([@B35]; [@B31]), *Enterococcus faecalis* Symbioflor 1 is efficacious for the treatment of sinusitis and bronchitis ([@B28]), and *E. faecium* JWS 833 enhances cytokine production by dendritic cells ([@B12]). Thus, enterococci are important for the health of humans and animals, as well as in the food industry and the environment.

Lactic acid bacteria produce antimicrobial substances that include organic acids, hydrogen peroxide, and bacteriocins. Bacteriocins have potent inhibitory activity against sensitive strains of bacteria. There are four classes (I--IV) of bacteriocins ([@B56]; [@B38]). Class I bacteriocins are \<5 kDa. They are posttranslationally modified peptides, which contain non-standard amino acids, such as lanthionine and β-methyllanthionine. The class I bacteriocins comprise three subgroups: class Ia (lantibiotics), class Ib (labyrinthopeptins), and class Ic (sanctibiotics) ([@B49]). Class II bacteriocins (5--10 kDa) are heat-stable unmodified peptides, which comprise four subgroups: class IIa (pediocin-like bacteriocins), class IIb (two-peptide bacteriocins), class IIc (circular bacteriocins), and class IId (linear and non-pediocin-like bacteriocins) ([@B18]). Class III bacteriocins (\>30 kDa) are heat-labile proteins, which include colicins, helveticin M, helveticin J, and enterolysin A ([@B38]). Class IV bacteriocins are large complexes with lipid or carbohydrate moieties. They are now termed bacteriolysins ([@B42]). Generally, class IIa bacteriocins consist of a conserved YGNGV motif and disulfide bond linkage ([@B53]).

Enterocin is a bacteriocin obtained from the *Enterococcus* species. Numerous enterocin-producing enterococci and enterocins have been reported. They include enterocin A from *E. faecium* CTC492 ([@B4]), enterocin B from *E. faecium* T136 ([@B9]), enterocin P from *E. faecium* P13 ([@B13]), and enterocin Q from *E. faecium* L50 ([@B14]). Class IIa enterocins are synthesized as a precursor with an N-terminal signal peptide, which is cleaved by adenosine triphosphate (ATP)-binding cassette (ABC) transporter ([@B29]) or the Sec secretion system ([@B13]). The type of N-terminal signal peptide determines the synthetic mechanism of enterocin. Although bacteriocins and producer cells play an essential role in the food industry, few studies have examined the biosynthetic mechanism and practical application of enterocins.

Virulence factors and antibiotic resistance are important in the pathogenicity of *E. faecalis*. Many virulence genes have been reported in enterococci, including cytolysins (*cylA*, *cylB*, and *cylM*), gelatinase (*gelE*), sex pheromones (*cpd*, *cob*, and *ccf*), aggregation substance gene (*agg*), and extracellular surface protein gene (*esp*, *efaAfs*, and *efaAfm*) ([@B6]; [@B10]). Moreover, several antibiotic resistance genes have been described in enterococci. These include genes conferring resistance to erythromycin (*ermB*, *ermC*), tetracycline (*tetM*, *tetS*, *tetO*, *tetK*, and *tetL*), ciprofloxacin (*gyrA* and *parC*), ampicillin (*bla*), and vancomycin (*vanA*, *vanB*, and *vanC*) ([@B46]; [@B26]; [@B16]; [@B27]).

In the present study, the complete genome sequence of *E. faecalis* Gr17, a novel strain isolated from a Chinese traditional low-salt fermented whole-fish product, was determined. The biosynthetic mechanism of enterocin Gr17, a novel bacteriocin from *E. faecalis* Gr17, was analyzed by bioinformatic analyses. Furthermore, the physicochemical characterization and antibacterial activity of purified enterocin Gr17 were determined. The genome information of *E. faecalis* Gr17 and the antibacterial properties of enterocin Gr17 provide the theoretical foundation for the potential use of the bacteriocin as a food preservative.

Materials and Methods {#S2}
=====================

Samples and Bacterial Culture Conditions {#S2.SS1}
----------------------------------------

Samples of the Chinese traditional low-salt fermented whole-fish product known as Suan yu were collected from the Dong ethnic minority regions in Liping, Guizhou Province, China. All LAB strains were cultured in MRS medium without agitation at 37°C. The details of each medium used for the indicator strain are provided in [Table 1](#T1){ref-type="table"}. All bacteria were grown at 37°C and stored at −80°C in culture broth containing 20% glycerol (v/v).

###### 

Antimicrobial spectrum of enterocin Gr17.

  **Indictor strains**                  **Source^a^**   **Media**   **Sensitivity^b^**
  ------------------------------------- --------------- ----------- --------------------
  *Listeria monocytogenes* 35152 (4b)   ATCC            TSYEB       +++
  *L. monocytogenes* 54002 (1/2a)       CMCC            TSYEB       +++
  *L. monocytogenes* 19112 (2a)         ATCC            TSYEB       ++
  *L. monocytogenes* 19113 (3a)         ATCC            TSYEB       +++
  *L. monocytogenes* 19114 (4a)         ATCC            TSYEB       ++
  *L. ivanovii* 19119                   ATCC            TSYEB       ++
  *L. grayi* 19120                      ATCC            TSYEB       ++
  *L. seeligeri* 35967                  ATCC            TSYEB       ++
  *L. innocua* 33090                    ATCC            TSYEB       +++
  *Staphylococcus aureus* 6538          ATCC            TSB         ++
  *S. aureus* 1.128                     CGMCC           TSB         +++
  *S. aureus* 1.1477                    CGMCC           TSB         ++
  *S. aureus* 26112                     CVCC            TSB         +++
  *S. aureus* 26923                     CVCC            TSB         +++
  *S. aureus* 29213                     ATCC            TSB         +++
  *Bacillus subtilis 10275*             CICC            LB          ++
  *B. subtilis 1.399*                   CGMCC           LB          +++
  *B. subtilis 6633*                    ATCC            LB          ++
  *B. subtilis 1.7740*                  CGMCC           LB          +++
  *B. subtilis 1.15792*                 CGMCC           LB          ++
  *B. subtilis 1.8715*                  CGMCC           LB          +++
  *B. cereus 63303*                     CMCC            LB          +++
  *B. cereus 14579*                     ATCC            LB          +++
  *B. cereus 11778*                     ATCC            LB          +++
  *B. cereus 1.229*                     CGMCC           LB          ++
  *B. cereus 1.0559*                    CGMCC           LB          ++
  *B. cereus 1.1626*                    CGMCC           LB          ++
  *B. anthracis*                        LAB             LB          ++
  *Brochothrix thermosphacta*           LAB             LB          ++
  *E. coli* 8739                        ATCC            LB          +++
  *E. coli* 1.90                        CGMCC           LB          +++
  *E. coli* 25922                       ATCC            LB          \+
  *E. coli* 10389                       CICC            LB          ++
  *Salmonella* C500                     CVCC            LB          \+
  *Salmonella enteritidis* 13076        ATCC            LB          −
  *S. enteritidis* 21513                CICC            LB          \+
  *S. infantis* 21482                   CICC            LB          −
  *Enterococcus faecalis* 29122         ATCC            TSB         +++
  *Pseudomonas aeruginosa* 21636        CICC            LB          \+
  *P. aeruginosa* 9027                  ATCC            LB          \+
  *P. fluorescens* 1.55                 CGMCC           LB          \+
  *P. fluorescens* 1.1802               CGMCC           LB          \+
  *Cronobacer sakazakii* 51329          ATCC            LB          \+
  *Aspergillus flavus* 40375            CICC            YPD         −
  *Penicillium citrinum* 4010           CICC            YPD         −
  *Aspergillus niger* 98003             CMCC            YPD         −
  *Candida albicans* 98001              CMCC            YPD         \+

a

CMCC, National Center for Medical Culture Collections; ATCC, American Type Culture Collection; CGMCC, China Center of General Microbial Culture Collection; CVCC, China Center of Veterinary Culture Collection; CICC, China Center of Industrial Culture Collection.

b

Inhibition zone (mm): +++, \>21 mm; ++, 11--20 mm; +, 1--10 mm; −, no inhibition.

Isolation of Bacteriocin-Producing LAB {#S2.SS2}
--------------------------------------

Liquid fermented fish samples (three cans) were mixed with 80 mL of sterile 0.9% NaCl. Serial dilutions were made using sterile 0.9% NaCl, and 1 mL of each dilution was spread on MRS agar. The plates were cultured at 37°C for 24 h. The 589 bacterial colonies that developed were each cultured in 2 mL of MRS broth for 24 h at 37°C. Each culture was centrifuged at 8,000 × *g* for 20 min at 4°C. The supernatant was recovered from each culture, the pH was adjusted to 7.0, and it was filtered through a 0.22-μm filter. The antibacterial activity in the filtered supernatant was determined by the well diffusion method ([@B64]). The 22 selected strains that displayed more pronounced antibacterial activity against the indicator strains (*Listeria monocytogenes* and *Escherichia coli*) were further tested with other indicator strains (*Staphylococcus aureus*, *Bacillus subtilis*, and *Bacillus cereus*). *E. faecalis* Gr17 displayed pronounced antibacterial activity and was selected for the subsequent experiments.

DNA Purification and Identification of Bacteriocin From *E. faecalis* Gr17 {#S2.SS3}
--------------------------------------------------------------------------

Strain Gr17 was cultured in MRS medium at 37°C without agitation. Genomic DNA was purified using the QIAamp DNA Mini Kit (Qiagen, Germany) according to instructions provided by the manufacturer. The concentration and purity of genomic DNA were assessed using a NanoDrop 2500 spectrophotometer (Thermo Fisher Scientific, MA, United States). Genotypic identification was performed according to the 16S rRNA gene sequence. The extracted genomic DNA was used as the PCR template. The primers were as follows: 16S rRNA-forward, 5′-AGAGTTTGATCCTGGCTCAG-3′; 16S rRNA-reverse: 5′-GGTTACCTTGTTACGACTT-3′. The 16S rRNA amplified as previously described ([@B57]) was sequenced by Sangon Biotech (Shanghai, China), after which the sequence was used for a BLAST search of the GenBank database.

Genome Sequencing and Assembly {#S2.SS4}
------------------------------

The complete genome of strain Gr17 was prepared using the PacBio platform. According to the protocol, a 20-kb DNA library was constructed and sequenced with Single Molecule, Real-Time (SMRT) technology. The sequences of SMRTCell were assembled by SMRT Pipe version 2.1.1. The reads were *de novo* assembled and polished using the Hierarchical Genome Assembly Process version 3/Quiver.

Genome Annotation {#S2.SS5}
-----------------

Gene prediction and annotation were carried out using the Glimmer 3.02 software^[1](#footnote1){ref-type="fn"}^ and the Rapid Annotation Search Tool (RAST) ([@B5]). Additional gene and function protein identification was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database ([@B34]) and Clusters of Orthologous Groups (COG) of proteins database ([@B62]).

Purification of Enterocin {#S2.SS6}
-------------------------

Strain Gr17 was grown in 100 mL of MRS broth to an optical density at 600 nm (OD~600~) of 0.4. A defined portion of the culture (0.5% v/v) was used to inoculate 2 L of MRS broth, which was incubated without agitation for 24 h at 37°C. The bacteria were removed by centrifugation at 8,000 × *g* for 20 min at 4°C. The supernatant was precipitated using 70% ammonium sulfate at 4°C and desalted by dialysis in sodium phosphate buffer (pH 6.5) with a cellulose semipermeable membrane (molecular weight cutoff, 1,000). The antibacterial activity of crude extracts was assayed, and the antibacterial samples were stored at −80°C.

The active extracts were further purified using the ÄKTA^TM^ pure system (GE, MA, United States). A SP-sepharose fast flow cation exchange column (16 × 25 mm) was equilibrated with 20 mM sodium phosphate buffer (pH 5.5), and the samples that had been filtered through a 0.22-μm filter were loaded onto the column and eluted with linear gradient from 0 to 1 M NaCl at a flow rate of 1 mL/min. The fractions were collected according to ultraviolet (UV) absorbance, and the antibacterial activity of collected fractions was assayed.

A Sephadex G25 column (26 × 100 mm) was equilibrated with 20 mM phosphate buffer (pH 5.5) and 2 mL of bacteriocin obtained from the cation exchange column was eluted by elution buffer (20 mM phosphate buffer) at a flow rate of 0.5 mL/min. The antibacterial activity of the collected fractions according to UV absorbance was assayed.

A C~18~ reverse-phase column (4.6 × 250 mm, 5 μm; Agilent, CA, United States) equipped with a reversed-phase high-performance liquid chromatography (RP-HPLC) system (Agilent) was used for further purification of bacteriocin. A linear gradient elution with 95% water--acetonitrile (5--95%) containing 0.1% trifluoroacetic acid (TFA) was used as the elution phase. The flow rate was 0.5 mL/min, and absorbance was monitored at 280 nm. The purified bacteriocin, which was designated enterocin Gr17, was collected and used to assess its antibacterial activity.

The antibacterial activity was assayed by the agar well diffusion method. The purity was assayed by tricine--sodium dodecyl sulfate (SDS)--polyacrylamide gel electrophoresis (PAGE). The concentration was determined using a Bicinchoninic Acid Kit (Thermo Fisher Scientific, MA, United States) according to the manufacturer's instructions.

Molecular Mass of Enterocin Gr17 {#S2.SS7}
--------------------------------

The molecular mass of purified enterocin Gr17 was determined by AB SCIEX 4700 matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI--TOF--MS) in linear mode (Applied Biosystems, CA, United States). Enterocin Gr17 was spotted on a target plate and left to dry. The dried enterocin was mixed with 0.5 μL of matrix solution containing α-cyano-4-hydroxycinnamic acid dissolved in 0.1% TFA (v/v) and 50% acetonitrile (v/v). Spectrometry was performed in positive ion mode.

Antibacterial Spectrum of Enterocin Gr17 {#S2.SS8}
----------------------------------------

The purified enterocin Gr17 obtained by RP-HPLC was used to determine its antibacterial spectrum against indicator strains containing food spoilage bacteria and food-borne pathogens.

Sensitivity to Heat, pH, Surfactants, and Proteolytic Enzymes {#S2.SS9}
-------------------------------------------------------------

The purified enterocin Gr17 obtained by RP-HPLC was assessed. To determine the effect of temperature on antibacterial activity, enterocin Gr17 was incubated at 60, 80, and 100°C for 30 min, and at 121°C for 15 min. The residual antibacterial activity was tested, and the sample at 37°C was used as the control.

The pH stability of enterocin Gr17 was estimated by adjusting the pH between 2 and 11 with 1 M NaOH or 1 M HCl. After incubation for 3 h at 37°C, the pH was neutralized to pH 6.5 and the residual antibacterial activity was tested.

The effect of ethylenediaminetetraacetic acid (EDTA), SDS, Tween 20, Tween 80, and urea (1%, v/v, final concentration) on enterocin Gr17 was assessed. After incubation for 3 h at 37°C, the residual antibacterial activity was tested.

The sensitivity of enterocin Gr17 to various proteolytic enzymes was determined by mixing 80 μL of enterocin Gr17 with 20 μL of enzymes (1 mg/mL, Sigma--Aldrich, MO, United States) including pepsin (pH 3.0), papain (pH 6.5), proteinase K (pH 7.5), trypsin (pH 7.6), and chymotrypsin (pH 7.8) for 3 h at 37°C. The control lacked enzyme.

Statistical Analyses {#S2.SS10}
--------------------

All experiments were performed in triplicate. Results were analyzed by analysis of variance (ANOVA) and Duncan's test with the SPSS 23.0 software (SPSS, IL, United States). All results are presented as mean ± standard deviations (SDs). A *P*-value \< 0.05 was considered statistically significant.

Results {#S3}
=======

Isolation of Bacteriocin-Producing Strains {#S3.SS1}
------------------------------------------

A total of 589 single bacterial colonies were isolated from Suan yu. The cell-free supernatant of 22 strains (pH 7.0) showed higher antibacterial activity against indicator strains (*L. monocytogenes* and *E. coli*). Strain Gr17 possessed antibacterial activity against *S. aureus*, *B. subtilis*, and *B. cereus.*

Identification and Genome Features of Strain Gr17 {#S3.SS2}
-------------------------------------------------

The complete genome and 16S rRNA analysis information identified strain Gr17 as *E. faecalis*. The strain was designated *E. faecalis* Gr17. The complete genome of *E*. *faecalis* Gr17 consists of a 2,588,149-base pair (bp) circular chromosome and a 49,643-bp circular plasmid designated as pGR-1, with a GC content of 38.47 and 31.51 mol%, respectively. The coding genes, ribosomal RNAs, and transfer RNAs of the chromosome and plasmid pGR17 are listed in [Table 2](#T2){ref-type="table"}. Additional gene and function protein identification was performed using the KEGG database ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}) and RAST ([Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Based on the COG database of proteins ([@B62]), the proteins were divided into functional categories ([Table 3](#T3){ref-type="table"}). Specially, the immune-related proteins unique for bacteriocin-producing strains belonged to the defense mechanism category. The information of complete genome and COG is listed in [Figure 1](#F1){ref-type="fig"} and has been deposited at GenBank under the accession numbers CP033376 and CP033377.

###### 

Features of *Enterococcus faecalis* Gr17 genome.

  **Attributes**      **Chromosome**   **Plasmid**
  ------------------- ---------------- -------------
  Genome size (bp)    2,588,149        49,643
  GC content (mol%)   38.47            31.51
  rRNAs               18               0
  tRNAs               67               0
  Coding proteins     2,053            72

###### 

COG categories of coding proteins in *Enterococcus faecalis* Gr17 genome.

  **COG class**   **Name**                                                                  **Count**   **Proportion (%)**
  --------------- ------------------------------------------------------------------------- ----------- --------------------
  C               Energy production and conversion                                          61          4.54
  D               Cell cycle control, cell division, chromosome partitioning partitioning   16          1.19
  E               Amino acid transport and metabolism                                       83          6.18
  F               Nucleotide transport and metabolism                                       59          4.39
  G               Carbohydrate transport and metabolism                                     179         13.33
  H               Coenzyme transport and metabolism                                         27          2.01
  I               Lipid transport and metabolism                                            40          2.98
  J               Translation, ribosomal structure, and biogenesis                          139         10.35
  K               Transcription                                                             96          7.15
  L               Replication, recombination, and repair                                    100         7.45
  M               Cell wall/membrane/envelope biogenesis                                    68          5.06
  N               Cell motility                                                             5           0.37
  O               Posttranslational modification, protein turnover, chaperones              47          3.50
  P               Inorganic ion transport and metabolism                                    80          5.96
  Q               Secondary metabolites biosynthesis, transport, and catabolism             11          0.82
  R               General function prediction only                                          112         8.34
  S               Function unknown                                                          147         10.95
  T               Signal transduction mechanisms                                            32          2.38
  U               Intracellular trafficking, secretion, and vesicular transport             12          0.89
  V               Defense mechanisms                                                        29          2.16

![Circular genome map of *Enterococcus faecalis* Gr17. Ring 1: genome sequences. Rings 2 and 3: COG annotated coding sequences. Ring 4: KEGG enzymes. Ring 5: RNA genes. Ring 6: GC content. Ring 7: GC skew. Very short features were enlarged to enhance visibility. Clustered genes, such as several rRNA genes, may appear as one line due to space limitations. The image was created by using Circos software.](fmicb-10-01806-g001){#F1}

Gene Cluster of Enterocin Gr17 {#S3.SS3}
------------------------------

The enterocin Gr17 gene was located on the plasmid. The conserved N-terminal YGNGV motif of mature class IIa bacteriocin was identified in enterocin Gr17 ([Figure 2A](#F2){ref-type="fig"}). Thus, enterocin Gr17 was identified as a class IIa bacteriocin. Also, the type of N-terminal signal peptide of the enterocin Gr17 precursor revealed that the biosynthesis and secretion process of enterocin Gr17 were *via* the Sec-dependent secretion system. Generally, the biosynthetic gene cluster of enterocin Gr17 contained a structural gene, transporter genes, and immunity gene within three divergent operons ([@B7]). As shown in [Figure 2B](#F2){ref-type="fig"}, the structural gene was composed of a precursor gene (EA467_13550), whose product could be cleaved to form an N-terminal leader peptide and mature antibacterial bacteriocin ([@B33]). The transporter genes encoded SecA protein (EA467_12775), an ATPase interacting with SecB protein and SecYEG complex; SecB protein (EA467_00140), which is responsible for recognition of nascent enterocin Gr17; and SecYEG complex (EA467_09045, EA467_06915, and EA467_12635), which facilitates the removal of signal peptide and secretion of mature enterocin Gr17. The immunity gene (EA467_13555) product could protect producer cells from mature enterocin Gr17. The comparison data with other closely related enterocin gene clusters are shown in [Figure 2C](#F2){ref-type="fig"}. The structural gene displayed 97.50, 92.50, and 95.85% homology to enterocin P from *E. faecium* CWBI_B1430 and *E. faecium* CRL1385, respectively, and the immunity gene showed 100, 95.52, and 93.29% homology to the immunity genes of enterocin P from *E. faecium* CWBI_B1430 and *E. faecium* CRL1385, respectively.

![The amino acid sequences of precursor peptides encoded by structural gene **(A)**, biosynthetic mechanism of enterocin Gr17 in *E. faecalis* Gr17 **(B)**, and the comparison with other closely related enterocin gene clusters **(C)**.](fmicb-10-01806-g002){#F2}

Virulence Factors and Antibiotic Resistance {#S3.SS4}
-------------------------------------------

The genes related to virulence factors, which included those encoding cytolysins (*cylA*, *cylB*, and *cylM*), gelatinase (*gelE*), sex pheromones (*cpd*, *cob*, and *ccf*), aggregation substance (*agg*), and extracellular surface proteins (*esp*, *efaAfs*, and *efaAfm*), were not found in the complete genome sequence of *E. faecalis* Gr17. Also, *E. faecalis* Gr17 did not contain antibiotic resistance genes encoding resistance to erythromycin (*ermB* and *ermC*), tetracycline (*tetM*, *tetS*, *tetO*, *tetK*, and *tetL*), ampicillin (*bla*), and vancomycin (*vanA*, *vanB*, and *vanC*). However, genes encoding resistance to ciprofloxacin (*gyrA* and *parC*) were located at EA467_08690 and EA467_03720.

Purification of Enterocin Gr17 {#S3.SS5}
------------------------------

Crude enterocin Gr17 was extracted from fermentation supernatant by ammonium sulfate precipitation. Approximately 2.12-fold purification and 85.73% recovery were achieved ([Table 4](#T4){ref-type="table"}). SP-sepharose fast flow cation exchange column purification ([Figure 3A](#F3){ref-type="fig"}) detected the active fraction at approximately 40 min elution time. The protein was purified 17.92-fold with 36.08% recovery. Sephadex G10 gel filtration chromatography purification yielded three different peptide fractions, with the active fraction eluted at approximately 30 min ([Figure 3B](#F3){ref-type="fig"}). This process increased the antibacterial activity 65.6-fold, and 27.01% of the initial activity was recovered. RP-HPLC increased antibacterial activity 87.37-fold and the recovery was 5.77% ([Figure 3C](#F3){ref-type="fig"}).

###### 

Purification of enterocin Gr17.

  **Purification Stage**           **Volume (mL)**   **Total protein (mg)**   **Total activity (AU)**   **Specific activity (AU/mg)**   **Purification fold**   **Recovery (%)**
  -------------------------------- ----------------- ------------------------ ------------------------- ------------------------------- ----------------------- ------------------
  Culture supernatant              1, 000            2,529                    302, 100                  119.45                          1                       100
  Ammonium sulfate precipitation   30                1,021                    259, 000                  253.67                          2.12                    85.73
  SP-sepharose fast flow           12                50.9                     109, 000                  2, 141.45                       17.92                   36.08
  Sephadex G10                     5                 10.5                     81, 600                   7, 771.43                       65.06                   27.01
  RP-HPLC                          1                 1.67                     17, 430                   10, 437.12                      87.37                   5.77

![Purification of enterocin Gr17 from *E. faecalis* Gr17 by column chromatography. **(A)** Cation exchange column. **(B)** Gel filtration chromatography. **(C)** RP-HPLC. **(D)** Mass spectrum of enterocin Gr17 by MALDI--TOF--MS. a, process of purification; b, antibacterial activity of peaks against indicator strain by agar well diffusion assay; c, tricine--SDS--PAGE of activity fraction.](fmicb-10-01806-g003){#F3}

Molecular Mass and Sequence of Enterocin Gr17 {#S3.SS6}
---------------------------------------------

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry revealed that the molecular mass of enterocin Gr17 was 4,531.01 Da ([Figure 3D](#F3){ref-type="fig"}). The complete genome sequence and molecular mass data indicated that the entire amino acid sequence was RSYGNGVYCNNSKCWVNWGEAKENIIGI VISGWATGLAGMGR. Due to the formation of an essential disulfide bond ([@B20]), the determined molecular mass was similar to the calculated mass. Enterocin Gr17 was different from reported bacteriocins in the protein BLAST search of the GenBank database^[2](#footnote2){ref-type="fn"}^. Furthermore, sequence alignment with other mature class IIa bacteriocins showed that enterocin Gr17 has a novel amino acid sequence ([Figure 4](#F4){ref-type="fig"}). The findings indicated that enterocin Gr17 from *E*. *faecalis* Gr17 is a novel class IIa bacteriocin with similarities to enterocin P.

![Alignment of reported class IIa bacteriocins. Alignments were obtained using DNAMAN 9.0 with default settings.](fmicb-10-01806-g004){#F4}

Antibacterial Spectrum of Enterocin Gr17 {#S3.SS7}
----------------------------------------

Enterocin Gr17 displayed strong antibacterial activity against Gram-positive bacteria (*L. monocytogenes*, *S. aureus*, *B. subtilis*, *B. cereus*, and *E. faecalis*) and poor antibacterial activity against Gram-negative bacteria (*E. coli*, *Salmonella enteritidis*, *Brochothrix thermosphacta*, *Pseudomonas aeruginosa*, *Pseudomonas fluorescens*, and *Cronobacter sakazakii*) and against the pathogenic yeast *Candida albicans* ([Table 1](#T1){ref-type="table"}).

Stability of Enterocin Gr17 {#S3.SS8}
---------------------------

After heating at different temperatures, enterocin Gr17 still possessed antibacterial activity ([Figure 5A](#F5){ref-type="fig"}). Enterocin Gr17 retained inhibitory activity at pH ranging from 2 to 10, but the activity was lost in pH 11 ([Figure 5B](#F5){ref-type="fig"}). Surfactants did not decrease the activity ([Figure 5C](#F5){ref-type="fig"}), and the activity was completely eliminated when incubated with proteolytic enzymes ([Figure 5D](#F5){ref-type="fig"}).

![Effects of temperature **(A)**, pH **(B)**, surfactants **(C)**, and protease **(D)** on the stability of enterocin Gr17.](fmicb-10-01806-g005){#F5}

Discussion {#S4}
==========

Numerous enterocins from *E. faecium* have been reported. These include the class IIa enterocin NKR-5-3C from *E. faecium* NKR-5-3C ([@B30]), class IIa enterocin TW21 from *E. faecium* D081821 ([@B11]), class IIc enterocin AS-48 ([@B1]), and class IId enterocin K1 ([@B47]). Even though features of the various enterocins have been determined, genome information and details of the biosynthesis mechanisms have been unknown. Also, the genome information of enterocin-producing strains, including *E. faecium* ICIS 96 ([@B51]), *E*. *faecium* CRL1879 ([@B8]), and *E*. *faecium* M3K31 ([@B3]), has been identified, but the features and biosynthesis mechanisms have also been unclear. The present findings reveal the biosynthesis mechanism and features of the novel class IIa enterocin Gr17 in the novel strain *E*. *faecalis* Gr17.

The potential of bacteriocins and bacteriocin-producing LAB as biopreservatives for fermented fish product has inspired searches for strains with potent antagonistic effects against food-poisoning microorganisms from fermented fish. Recent studies have isolated and screened bacteriocin-producing strains from fermented fish in different countries ([Table 5](#T5){ref-type="table"}). However, bacteriocin-producing strains isolated from Chinese fermented fish have not been adequately studied; as far as we know, the only bacteriocin-producing bacterium is *Lactobacillus plantarum* LPL-1, which was isolated from Chinese fermented sturgeon fish products ([@B65]). In this manuscript, we isolated a novel bacteriocin producer, *E. faecalis* Gr17, from Suan yu, a Chinese traditional low-salt fermented whole-fish product. This is the first report of a novel bacteriocin-producing strain from Suan yu. The antibacterial activity and spectrum of bacteriocins are important factors for the application of bacteriocins in the food industry. The novel amino acid sequence of bacteriocins could provide a foundation for exploring the relationship between bacteriocin structure and antibacterial activity. The characteristics, molecular mass, and amino acid sequence of enterocin Gr17 are obviously different from some well-known enterocins.

###### 

The bacteriocin-producing strains from fermented fish of different countries.

  **Bacteriocin-producing strain**            **Bacteriocin**      **Source**                                      **References**
  ------------------------------------------- -------------------- ----------------------------------------------- ----------------
  *Weissella cibaria* 110                     Weissellicin 110     Thai fermented fish product (plaa-som)          [@B61]
  *Staphylococcus hominis* KQU-131            Nukacin KQU-131      Thai fermented fish product (Pla-ra)            [@B66]
  *Pediococcus pentosaceus* CFF4              Bacteriocin CFF4     Cambodian fermented fish (pha ak trey)          [@B52]
  *Lactobacillus plantarum* LPL-1             Plantaricin LPL-1    Chinese fermented sturgeon fish products        [@B65]
  *Lactococcus lactis* ssp. *Lactis* HKBT-9   Bacteriocin HKBT-9   India fermented Fish Product (Hukuti Maas)      [@B37]
  *Weissella confusa* N23                     Bacteriocin N23      Thai fermented meat and fish products           [@B54]
  *Lactococcus lactis* NK24                   Lacticin NK24        Korean fermented fish product (jeot-gal)        [@B40]
  *Enterococcus faecium* DB1                  Enterocin DB1        Korean fermented fish product (gajami sikhae)   [@B39]
  *Enterococcus faecalis* F4-9                Enterocin F4-9       Egyptian salted-fermented fish                  [@B43]
  *Enterococcus faecium* NKR-5-3              Enterocin NKR-5-3    Thai fermented fish products                    [@B30]

Cytolysin encoded by *cylA*, *cylB*, and *cylM* is a bacterial toxin that increases the risks of illness and death. Gelatinase encoded by *gelE* participates in the initiation and propagation of inflammatory processes. Sex pheromones encoded by *cpd*, *cob*, and *ccf*, and aggregation substance encoded by *agg* cause cell aggregation and facilitate the transfer of virulence factors and antibiotic resistance genes. Extracellular surface proteins encoded by *esp*, *efaAfs*, and *efaAfm* can promote adhesion of cells and protect the cells from the immune system. These virulence factors were not detected in *E. faecalis* Gr17, which suggests that the strain is non-virulent and relatively safe for consumers. Also, *E. faecalis* Gr17 did not contain genes encoding resistance to erythromycin, tetracycline, ampicillin, and vancomycin, but could potentially be resistant to ciprofloxacin. We screened *E. faecalis* Gr17 from the fermented whole-fish product Suan yu. Ciprofloxacin was often used to protect fish from pathogenic bacteria in aquaculture. It is conceivable that *E. faecalis* Gr17 may be transmissible from fish by highly efficient gene transfer mechanisms. Still, the available genotypic evidence of potential virulence factors and antibiotic resistance indicates that the strain may be safe to use.

Class IIa enterocins can be exported from cells by the Sec system (e.g., enterocin P in *E. faecium* P13; [@B13]) and the ABC transporter (e.g., enterocin B in *E. faecium* T136; [@B9]). Also, the biosynthetic mechanisms of other enterocins, which are termed leaderless bacteriocins, are unclear; these enterocins include enterocin K1 ([@B47]) and EntEJ97 ([@B48]). The biosynthetic mechanism of enterocin Gr17 belonged to the Sec system according to the complete genome information of *E. faecalis* Gr17. The genes relevant to the structural gene, transporter genes, and immune-related gene were identified. Moreover, the specific function of relevant genes was predicted by bioinformatic analysis. This genome information of *E. faecalis* Gr17 provides a better understanding of the biosynthesis mechanism of enterocin Gr17. Further investigations of the relevance between the quorum sensing system and biosynthesis of enterocin Gr17 will be carried out.

The precursor of class IIa enterocins is composed of signal peptide and mature peptide ([@B33]). Generally, the cleavage site between the signal peptide and mature peptide could be determined by bioinformatic analysis and MALDI--TOF--MS. According to the genome information, the amino acid sequence of the precursor was determined. Enterocin Gr17 was identified as a class IIa bacteriocin because of the N-terminal conserved YGNGV motif of mature class IIa bacteriocin. To determine the molecular mass of the mature peptide, enterocin Gr17 was purified by salt precipitation, cation exchange, gel filtration chromatography, and RP-HPLC. Different from other enterocins, such as enterocin RM6 (7145.0823 Da) ([@B32]), enterocin TW21 (5302.98 Da) ([@B11]), and enterocin AS-48 (7149 Da) ([@B1]), the molecular mass of purified enterocin Gr17 was 4,531.01 Da, which corresponded to a calculated molecular mass of 4,533.11 Da due to the formation of a disulfide bond. To some extent, the molecular mass result confirmed the novelty of enterocin Gr17. Especially, the results of genome information and MALDI--TOF--MS revealed that the amino acid sequence of mature enterocin Gr17 was RSY GNGVYCNNSKCWVNWGEAKENIIGIVISGWATGLAGMGR. A BLAST search of the NCBI database^[3](#footnote3){ref-type="fn"}^ for mature enterocin Gr17 revealed its difference from reported class IIa enterocins. Therefore, enterocin Gr17 was confirmed as a novel class IIa enterocin. Compared with known class IIa bacteriocins, the enterocin Gr17 possesses a similar N-terminal sequence of xxYGNGVxC.

The antibacterial activity of enterocins can provide a basis for their application as food biopreservatives. In contrast to the narrow spectrum bacteriocins enterocin W ([@B60]), enterocin A ([@B21]), enterocin 416K1 ([@B58]), and enterocin CRL35 ([@B59]), enterocin Gr17 possessed antibacterial activity against *L*. *monocytogenes*, *S*. *aureus*, *B*. *subtilis*, *B*. *cereus*, *B. anthracis*, *E*. *coli*, *S*. *enteritidis*, *P*. *aeruginosa*, *P. fluorescens*, *E. faecalis*, *E*. *sakazakii*, and *C*. *albicans* ([Table 1](#T1){ref-type="table"}). These food-borne pathogenic and spoilage bacteria are also most frequently detected in the food industry and in medical science. Numerous authors also combined bacteriocins with the hurdle technology to inhibit food-borne pathogenic bacteria ([@B41]), such as chemical chelators (sodium tripolyphosphate and EDTA) and physical methods (pH, temperature, high hydrostatic pressure, and pulsed electric field) ([@B63]; [@B2]; [@B44]; [@B36]; [@B55]). Thus, enterocin Gr17 has the potential to be applied with the hurdle technology to control food quality. The antibacterial activity of enterocin Gr17 makes it a good candidate for the preservation of various types of foods.

Concerning the application of enterocin Gr17 in the biopreservation of foods, its stability during different chemical treatments is essential. Enterocin Gr17 was very stable to a wide range of pH, high temperatures, and surfactants. These features are typical of the numerous bacteriocins that have been characterized, such as enterocin from *E*. *faecium* JCM 5804T ([@B50]), enterocin ON-157 from *E*. *faecium* NIAI 157 ([@B46]), and enterocin RM6 ([@B32]). The thermal stability of enterocin Gr17 indicates that it is valuable for use in dairy products and heat-processed foods. The pH stability could allow its use with slightly alkaline, neutral, and acidic foods. The surfactant stability could be ideal for use in emulsified foods. The antibacterial activity of enterocin could be destroyed by human digestive enzymes. To a certain extent, enterocin Gr17 could be safely used in the food industry, and safety for the human health remains to be confirmed by toxicity experiments in the future. Therefore, enterocin Gr17 is a good candidate as a safe biopreservative in the food industry.

Generally, the formation of pores in the membrane of cells is lethal. To definitively analyze the antibacterial mechanism of enterocin Gr17 against food-borne pathogenic and spoilage bacteria, further investigations on morphology changes will be done using scanning tunneling microscopy, transmission electron microscopy, and atomic force microscopy, and the exchange of molecules between inner and outer membrane of Gram-negative bacteria will be explored using proton motive force. As well, ATP and inorganic ions will be examined. Metabolomics, transcriptomics, and proteomics data will be combined to clarify the antibacterial mechanism.

Conclusion {#S5}
==========

Bioinformatic analysis clarified the biosynthetic mechanism of enterocin Gr17 in the novel strain *E. faecalis* Gr17. Based on bioinformation and MALDI--TOF--MS, enterocin Gr17 from *E*. *faecalis* Gr17 was identified. The entire amino acid sequence was determined to be RSYGNGVYCNNSK CWVNWGEAKENIIGIVISGWATGLAGMGR. Enterocin Gr17 exhibited bactericidal activity, sensitivity to enzymes, and stability to chemicals, elevated temperature, and pH. Therefore, enterocin Gr17 is a promising stable and safe biopreservative in various types of foods. Future investigations on the bactericidal mechanism of enterocin Gr17 will be carried out.
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